Mechanism of action of Atibuclimab
Atibuclimab (IC14) is a chimeric CD14 antibody investigated for the treatment of patients with severe sepsis. It is Investigated for use/treatment in sepsis and septicemia and pneumonia.
Sep 6，2022
